BeStock  
Stocks › Biotechnology › RXRX

Recursion Pharmaceuticals RXRX

US equityMarket cap rank #2603BiotechnologyAI medical concept stocks
$4.78 +$0.66 (+16.02%)
Pre-market · Oct 6, 4:10 am ET · After hours $4.76 -0.42%
Open$4.16
Prev close$4.12
Day range$4.06 – $4.94
Volume67.28M
Market cap$2.56B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts5
Average target$6.65+39.1% vs. price
  • Buy 40%
  • Hold 60%
Low $5.30Now $4.78Avg $6.65High $8.00

Recent rating changes

The last 20 actions on file set price targets from $5.30 to $10.00, averaging $6.92.

DateFirmRatingTarget
21 Sep 2026 BofA Securities HOLD –
15 Sep 2026 J.P. Morgan BUY –
17 Aug 2026 Morgan Stanley HOLD $5.30
12 Aug 2026 BofA Securities HOLD $6.00
7 Aug 2026 BofA Securities HOLD $6.00
5 Aug 2026 TD Cowen HOLD –
5 Aug 2026 Needham BUY $8.00
14 May 2026 Morgan Stanley HOLD $5.50
13 May 2026 BofA Securities HOLD $6.00
7 May 2026 BofA Securities HOLD $6.00
7 May 2026 Needham BUY $8.00
6 May 2026 TD Cowen HOLD –
30 Apr 2026 J.P. Morgan BUY $10.00
14 Apr 2026 Needham BUY $8.00
25 Feb 2026 TD Cowen HOLD –
25 Feb 2026 BofA Securities HOLD $6.00
25 Feb 2026 Needham BUY $8.00
14 Jan 2026 BofA Securities HOLD $7.00
12 Jan 2026 BofA Securities HOLD $7.00
6 Jan 2026 BofA Securities HOLD $7.00

Discussion

No comments yet — be the first to weigh in on RXRX.

Leave a comment

Scroll to Top